Local Delivery of Protease-resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction.
From: Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass, USA.
Circulation
- Publish Date: Oct 2007
- ISSN: 1524-4539
- Volume: 116
- Issue: 15
- Pages: 1683-92
- Medium: Internet
- Language: English
- Citation (JAMA): Segers Vincent F M, Tokunou Tomotake, Higgins Luke J, et al. Local Delivery of Protease-resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction.. Circulation Oct 2007;116:1683-92
Abstract
BACKGROUND: Local delivery of chemotactic factors represents a novel approach to tissue regeneration. However, successful chemokine protein delivery is challenged by barriers including the rapid diffusion of chemokines and cleavage of chemokines by proteases that are activated in injured tissues. Stromal cell-derived factor-1 (SDF-1) is a well-characterized chemokine for attracting stem cells and thus a strong candidate for promoting regeneration. However, SDF-1 is cleaved by exopeptidases and matrix metalloproteinase-2, generating a neurotoxin implicated in some forms of dementia. METHODS AND RESULTS: We designed a new chemokine called S-SDF-1(S4V) that is resistant to matrix metalloproteinase-2 and exopeptidase cleavage but retains chemotactic bioactivity, reducing the neurotoxic potential of native SDF-1. To deliver S-SDF-1(S4V), we expressed and purified fusion proteins to tether the chemokine to self-assembling peptides, which form nanofibers and allow local delivery. Intramyocardial delivery of S-SDF-1(S4V) after myocardial infarction recruited CXCR4+/c-Kit+ stem cells (46+/-7 to 119+/-18 cells per section) and increased capillary density (from 169+/-42 to 283+/-27 per 1 mm2). Furthermore, in a randomized, blinded study of 176 rats with myocardial infarction, nanofiber delivery of the protease-resistant S-SDF-1(S4V) improved cardiac function (ejection fraction increased from 34.0+/-2.5% to 50.7+/-3.1%), whereas native SDF-1 had no beneficial effects. CONCLUSIONS: The combined advances of a new, protease-resistant SDF-1 and nanofiber-mediated delivery promoted recruitment of stem cells and improved cardiac function after myocardial infarction. These data demonstrate that driving chemotaxis of stem cells by local chemokine delivery is a promising new strategy for tissue regeneration.
Mesh Headings (Keywords): Animals, Antigens, CD26, Blood Pressure, Carotid Arteries, Chemokine CXCL12, Chemokines, CXC, Drug Resistance, Hematopoietic Stem Cell Mobilization, Male, Matrix Metalloproteinase 2, Mutation, Myocardial Infarction, Neovascularization, Physiologic, Peptide Hydrolases, Plasmids, Rats, Rats, Sprague-Dawley, Regeneration, Stem Cells
Check for Full Text / PubMed Unique Identifier (PMID): 17875967
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.